← Back to headlines
Absci Outlines $25 Billion Market Potential for ABS-201 and Advances Endometriosis Program
Absci has projected a $25 billion annual market potential for its drug candidate ABS-201 in AGA and announced progress in its clinical program for endometriosis.
25 Mar, 00:55 — 25 Mar, 00:55
Sources
Showing 1 of 1 sources
